HIF1A and diabetes mellitus: In line with our observations, prior research has reported a high presence of HIF-1α-positive β-cells in diabetic mouse models [8], and PX-478 treatment has demonstrated efficacy in enhancing β-cell function in individuals with diabetes [2].